MARC Record from marc_columbia

LEADER: 04365cam a2200421Ic 4500
001 13238794
005 20180618184530.0
008 180205t20182018dcua b 000 0 eng d
020 $a9780309468053$q(paperback)
020 $a0309468051$q(paperback)
035 $a(OCoLC)on1021804288
035 $a(OCoLC)1021804288
035 $a(NNC)13238794
040 $aYDX$beng$erda$cYDX$dNRC$dKSU$dSOI
050 4 $aHD9666.4$b.M35 2018
245 00 $aMaking medicines affordable :$ba national imperative /$cNorman R. Augustine, Guru Madhavan, and Sharyl J. Nass, editors ; Committee on Ensuring Patient Access to Affordable Drug Therapies, Board on Health Care Services, Health and Medicine Division ; a consensus study report of the National Academies of Sciences, Engineering, Medicine.
264 1 $aWashington, DC :$bNational Academies Press,$c[2018]
264 4 $c©2018
300 $axxviii, 206 pages :$bcolor illustrations ;$c23 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aConsensus study report
520 $aThe United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicines--and health care at large--more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugs--coupled with the broader trends in overall health care costs--is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
504 $aIncludes bibliographical references (pages 135-157).
505 0 $aThe affordability conundrum -- Complexity in action -- Factors influencing affordability -- Strategies to improve affordability and availability -- References -- Appendixes.
650 0 $aDrugs$xPrices$zUnited States.
650 0 $aHealth services accessibility$xEconomic aspects$zUnited States.
650 0 $aPharmaceutical policy$zUnited States.
700 1 $aAugustine, Norman R.,$eeditor.
700 1 $aMadhavan, Guruprasad,$eeditor.
700 1 $aNass, Sharyl J.,$eeditor.
710 2 $aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bCommittee on Ensuring Patient Access to Affordable Drug Therapies.
710 2 $aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bBoard on Health Care Services.
710 2 $aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bHealth and Medicine Division.
776 08 $iOnline version$aNational Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Ensuring Patient Access to Affordable Drug Therapies.$tMaking medicines affordable.$dWashington, D.C. : National Academies Press, [2018]$w(OCoLC)1027967573
830 0 $aConsensus study report.
852 00 $boff,sci$hHD9666.4$i.M35 2018g